Small molecules interacting with α-synuclein: Antiaggregating and cytoprotective properties

Amino Acids

Volumn 45, Issue 2, 2013, Pages 327-338

  Marchiani, Anna ^a,b   Mammi, Stefano ^a,b   Siligardi, Giuliano ^c   Hussain, Rohanah ^c   Tessari, Isabella ^b   Bubacco, Luigi ^b   Delogu, Giovanna ^a   Fabbri, Davide ^a   Dettori, Maria A ^a   Sanna, Daniele ^a   Dedola, Sonia ^d   Serra, Pier A ^d   Ruzza, Paolo ^a  

^a CNR   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c DIAMOND LIGHT SOURCE LTD   (United Kingdom)

^d UNIVERSITY OF SASSARI   (Italy)

Author keywords

Synuclein; Biphenyl compounds; Curcumin like molecules; Parkinson's disease; Protein aggregation

Indexed keywords

6 (4 HYDROXY 3 METHYLPHENYL) 2,4 DIOXOHEXENAL; ALPHA SYNUCLEIN; BIPHENYL DERIVATIVE; CONGO RED; CURCUMIN; DEHYDROZINGERONE; DEHYDROZINGERONE DIMER; FERULIC ACID; HEXOBARBITAL; HYDROGEN PEROXIDE; MANGANESE CHLORIDE; O METHYL DEHYDROZINGERONE; O METHYL DEHYDROZINGERONE DIMER; POLYPHENOL; UNCLASSIFIED DRUG; VANILLIN; ZINGERONE; ZINGERONE DIMER;

ALZHEIMER DISEASE; ANIMAL CELL; ANTI PROTEIN AGGREGATION ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; CIRCULAR DICHROISM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG ACTIVITY; FLUORESCENCE SPECTROSCOPY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PC12 CELL; PH; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL;

ADRENAL GLAND NEOPLASMS; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; CELL LINE, TUMOR; CURCUMIN; CYTOPROTECTION; GUAIACOL; PARKINSON DISEASE; PHEOCHROMOCYTOMA; RATS; STYRENES;

RATTUS;

EID: 84880823470     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-013-1503-3     Document Type: Article

References (32)

1. Bartels T, Choi JG, Selkoe DJ (2011) alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477:107-111
2. Baures PW, Peterson SA, Kelly JW (1998) Discovering transthyretin amyloid fibril inhibitors by limited screening. Bioorg Med Chem 6:1389-1401
3. Brand-Williams W, Cuvelier ME, Berset C (1995) Use of a free radical method to evaluate antioxidant activity. LWT-Food Sci Technol. 28:25-30
4. Delogu G, Fabbri D, Dettori MA, Forni A, Casalone G (2000) Chiral nonracemic C2-symmetry biphenyls by desymmetrization of 6,6′,2,2′- tetramethoxy-1,1′-biphenyl. Tetrahedron Asymmetry 11:4417-4427
5. Delomenede M, Bedos-Belval F, Duran H, Vindis C, Baltas M, Negre-Salvayre A (2008) Development of novel antiatherogenic biaryls: design, synthesis, and reactivity. J Med Chem 51:3171-3181
6. Elias G, Rao MNA (1988) Synthesis and anti-inflammatory activity of substituted (e)-4-phenyl-3-buten-2-ones. Eur J Med Chem 23:379-380
7. Hauser DN, Hastings TG (2013) Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism. Neurobiol Dis 51:35-42
8. Hong DP, Fink AL, Uversky VN (2008) Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein. J Mol Biol 383:214-223
9. Howie AJ, Brewer DB (2009) Optical properties of amyloid stained by Congo red: history and mechanisms. Micron 40:285-301
10. Huang CJ, Ren GP, Zhou H, Wang CC (2005) A new method for purification of recombinant human alpha-synuclein in Escherichia coli. Protein Expr Purif 42:173-177
11. Jiang M, Xie MX, Zheng D, Liu Y, Li XY, Chen X (2004) Spectroscopic studies on the interaction of cinnamic acid and its hydroxyl derivatives with human serum albumin. J Mol Struct 692:71-80
12. Liu YZ, Dolence J, Ren J, Rao MNA, Sreejayan N (2008) Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function. J Cardiovasc Pharmacol 52:422-429
13. Marques FA, Simonelli F, Oliveira ARM, Gohr GL, Leal PC (1998) Oxidative coupling of 4-substituted 2-methoxy phenols using methyltributylammonium permanganate in dichloromethane. Tetrahedron Lett 39:943-946
14. Montalti M, Credi A, Prodi L, Gandolfi MT (2006) Handbook of photochemistry. CRC Press, Taylor & Francis Group, Boca Raton, pp 561-600
15. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
16. Naiki H, Nagai Y (2009) Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins. J Biochem 146:751-756
17. Narender T, Reddy KP (2007) A simple and highly efficient method for the synthesis of chalcones by using borontrifluoride-etherate. Tetrahedron Lett 48:3177-3180
18. Ono K, Yamada M (2006) Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. J Neurochem 97:105-115
19. Oueslati A, Fournier M, Lashuel HA (2010) Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies. In: Bjorklund A, Cenci M (eds) Recent Advances in Parkinsons Disease: Basic Research. Elsevier Science BV, Amsterdam, pp 115-145
20. Parihar VK, Dhawan J, Kumar S, Manjula SN, Subramanian G, Unnikrishnan MK, Rao CM (2007) Free radical scavenging and radioprotective activity of dehydrozingerone against whole body gamma irradiation in Swiss albino mice. Chem Biol Interact 170:49-58
21. Pisano M, Pagnan G, Dettori MA, Cossu S, Caffa I, Sassu I, Emionite L, Fabbri D, Cilli M, Pastorino F, Palmieri G, Delogu G, Ponzoni M, Rozzo C (2010) Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells. Mol Cancer 9:137-148
22. Priyadarsini KI, Guha SN, Rao MNA (1998) Physico-chemical properties and antioxidant activities of methoxy phenols. Free Radic Biol Med 24:933-941
23. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26:1231-1237
24. Roth J (2009) Are there common biochemical and molecular mechanisms controlling manganism and parkisonism. NeuroMol Med 11:281-296
25. Schildknecht S, Gerding HR, Karreman C, Drescher M, Lashuel HA, Outeiro TF, Di Monte DA, Leist M (2013) Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. J Neurochem. doi: 10.1111/jnc.12226
26. Siddiqui MA, Kashyap MP, Kumar V, Tripathi VK, Khanna VK, Yadav S, Pant AB (2011) Differential protection of pre-, co- and post-treatment of curcumin against hydrogen peroxide in PC12 cells. Hum Exp Toxicol 30:192-198
27. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15:1867-1876
28. Wang MS, Boddapati S, Emadi S, Sierks MR (2010) Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model. BMC Neurosci 11:57
29. Witting PK, Westerlund C, Stocker R (1996) A rapid and simple screening test for potential inhibitors of tocopherol-mediated peroxidation of LDL lipids. J Lipid Res 37:853-867
30. Xiang W, Schlachetzki JC, Helling S, Bussmann JC, Berlinghof M, Schäffer TE, Marcus K, Winkler J, Klucken J, Becker CM (2013) Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity. Mol Cell Neurosci 54:71-83
31. Xu J, Wei CZ, Xu CQ, Bennett MC, Zhang GH, Li FC, Tao EX (2007) Rifampicin protects PC12 cells against MPP+-induced apoptosis and inhibits the expression of an alpha-Synuclein multimer. Brain Res 1139:220-225
32. Zhou HY, Beevers CS, Huang SL (2011) The Targets of Curcumin. Curr Drug Targets 12:332-347